» Articles » PMID: 33008006

Anti-Obesity Effects of Soybean Embryo Extract and Enzymatically-Modified Isoquercitrin

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 Oct 3
PMID 33008006
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Soy isoflavones are bioactive phytoestrogens with known health benefits. Soybean embryo extract (SEE) has been consumed as a source of isoflavones, mainly daidzein, glycitein, and genistein. While previous studies have reported the anti-obesity effects of SEE, this study investigates their molecular mechanisms and the synergistic effects of co-treatment with SEE and enzymatically modified isoquercitrin (EMIQ). SEE upregulated genes involved in lipolysis and brown adipocyte markers and increased mitochondrial content in differentiated C3H10T1/2 adipocytes in vitro. Next, we use a high-fat diet-induced obesity mouse model to determine the anti-obesity effect of SEE. Two weeks of single or combined treatment with SEE and EMIQ significantly reduced body weight gain and improved glucose tolerance. Mechanistically, SEE treatment increased mitochondrial content and upregulated genes involved in lipolysis in adipose tissue through the cAMP/PKA-dependent signaling pathway. These effects required a cytosolic lipase adipose triglyceride lipase (ATGL) expression, confirmed by an adipocyte-specific ATGL knockout mouse study. Collectively, this study demonstrates that SEE exerts anti-obesity effects through the activation of adipose tissue metabolism and exhibits a synergistic effect of co-treatment with EMIQ. These results improve our understanding of the mechanisms underlying the anti-obesity effects of SEE related to adipose tissue metabolism.

Citing Articles

A Combination of Soy Isoflavone and L-Carnitine Improves Running Endurance in Mice.

Lee J, Joh Y, Choi C, Kim K, Lee Y Nutrients. 2023; 15(17).

PMID: 37686710 PMC: 10489700. DOI: 10.3390/nu15173678.


Synergistic Effects of Heat-Treated Green Tea Extract and Enzymatically-Modified Isoquercitrin in Preventing Obesity.

Moon Y, Kim H, Kim M, Im H, Lee Y Nutrients. 2023; 15(13).

PMID: 37447257 PMC: 10346566. DOI: 10.3390/nu15132931.


Integration of LC-MS-Based and GC-MS-Based Metabolic Profiling to Reveal the Effects of Domestication and Boiling on the Composition of Duck Egg Yolks.

Tian Y, Li G, Du X, Zeng T, Chen L, Xu W Metabolites. 2023; 13(1).

PMID: 36677059 PMC: 9866831. DOI: 10.3390/metabo13010135.


A Review on Obesity Management through Natural Compounds and a Green Nanomedicine-Based Approach.

Bhardwaj M, Yadav P, Vashishth D, Sharma K, Kumar A, Chahal J Molecules. 2021; 26(11).

PMID: 34071722 PMC: 8198321. DOI: 10.3390/molecules26113278.


Topical Collection "Pharmacology of Medicinal Plants".

Romano B, Lucariello G, Capasso R Biomolecules. 2021; 11(1).

PMID: 33466709 PMC: 7828774. DOI: 10.3390/biom11010101.

References
1.
Tang B . Sirt1 and the Mitochondria. Mol Cells. 2016; 39(2):87-95. PMC: 4757807. DOI: 10.14348/molcells.2016.2318. View

2.
Kim S, Kwon H, Akindehin S, Jeong H, Lee Y . Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes. Nutrients. 2017; 9(7). PMC: 5537795. DOI: 10.3390/nu9070680. View

3.
Li P, Zhu Z, Lu Y, Granneman J . Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-alpha. Am J Physiol Endocrinol Metab. 2005; 289(4):E617-26. DOI: 10.1152/ajpendo.00010.2005. View

4.
Wang L, Waltenberger B, Pferschy-Wenzig E, Blunder M, Liu X, Malainer C . Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol. 2014; 92(1):73-89. PMC: 4212005. DOI: 10.1016/j.bcp.2014.07.018. View

5.
Dang Z, Audinot V, Papapoulos S, Boutin J, Lowik C . Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem. 2002; 278(2):962-7. DOI: 10.1074/jbc.M209483200. View